Thus, in view of the necessity of new treatments for this pathology, our aim was to study the formation and function of CB1R-NMDAR complexes in an in vitro PD model consisting of neuronal primary cultures treated with α-syn, trying to show if CB1R-NMDAR complexes could have a role as therapeutic target in Parkinson’s disease. This evidence concerns the gene CNR1 and Parkinson disease.